IMMERSION CORPORATION (IMMR)

US4525211078 - Common Stock

8.66  +0.34 (+4.09%)

After market: 8.6001 -0.06 (-0.69%)

Fundamental Rating

7

IMMR gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 32 industry peers in the Technology Hardware, Storage & Peripherals industry. IMMR has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. A decent growth rate in combination with a cheap valuation! Better keep an eye on IMMR. With these ratings, IMMR could be worth investigating further for value and quality investing!.



7

1. Profitability

1.1 Basic Checks

IMMR had positive earnings in the past year.
IMMR had a positive operating cash flow in the past year.
Of the past 5 years IMMR 4 years were profitable.
Of the past 5 years IMMR 4 years had a positive operating cash flow.

1.2 Ratios

With an excellent Return On Assets value of 18.13%, IMMR belongs to the best of the industry, outperforming 93.75% of the companies in the same industry.
Looking at the Return On Equity, with a value of 22.02%, IMMR belongs to the top of the industry, outperforming 90.63% of the companies in the same industry.
The Return On Invested Capital of IMMR (11.54%) is better than 71.88% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for IMMR is significantly below the industry average of 16.81%.
The last Return On Invested Capital (11.54%) for IMMR is above the 3 year average (9.10%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 18.13%
ROE 22.02%
ROIC 11.54%
ROA(3y)13%
ROA(5y)5.72%
ROE(3y)15.61%
ROE(5y)6.28%
ROIC(3y)9.1%
ROIC(5y)N/A

1.3 Margins

Looking at the Profit Margin, with a value of 62.75%, IMMR belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
In the last couple of years the Profit Margin of IMMR has grown nicely.
The Operating Margin of IMMR (44.25%) is better than 100.00% of its industry peers.
IMMR's Operating Margin has improved in the last couple of years.
Industry RankSector Rank
OM 44.25%
PM (TTM) 62.75%
GM N/A
OM growth 3Y94.23%
OM growth 5Y2.01%
PM growth 3Y78.19%
PM growth 5Y15.41%
GM growth 3YN/A
GM growth 5YN/A

9

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so IMMR is still creating some value.
IMMR has less shares outstanding than it did 1 year ago.
The number of shares outstanding for IMMR has been increased compared to 5 years ago.
There is no outstanding debt for IMMR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

IMMR has an Altman-Z score of 5.13. This indicates that IMMR is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of IMMR (5.13) is better than 84.38% of its industry peers.
IMMR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 5.13
ROIC/WACC1.05
WACC10.99%

2.3 Liquidity

A Current Ratio of 6.44 indicates that IMMR has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 6.44, IMMR belongs to the top of the industry, outperforming 90.63% of the companies in the same industry.
IMMR has a Quick Ratio of 6.44. This indicates that IMMR is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 6.44, IMMR belongs to the best of the industry, outperforming 90.63% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 6.44
Quick Ratio 6.44

5

3. Growth

3.1 Past

IMMR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 58.28%, which is quite impressive.
Measured over the past years, IMMR shows a decrease in Earnings Per Share. The EPS has been decreasing by -9.60% on average per year.
The Revenue has grown by 338.29% in the past year. This is a very strong growth!
Measured over the past years, IMMR shows a very negative growth in Revenue. The Revenue has been decreasing by -21.11% on average per year.
EPS 1Y (TTM)58.28%
EPS 3Y47.44%
EPS 5Y-9.6%
EPS Q2Q%217.86%
Revenue 1Y (TTM)338.29%
Revenue growth 3Y3.61%
Revenue growth 5Y-21.11%
Sales Q2Q%650.44%

3.2 Future

IMMR is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -33.01% yearly.
Based on estimates for the next years, IMMR will show a very strong growth in Revenue. The Revenue will grow by 363.38% on average per year.
EPS Next Y75.07%
EPS Next 2Y-33.01%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year1039.86%
Revenue Next 2Y363.38%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

8

4. Valuation

4.1 Price/Earnings Ratio

IMMR is valuated cheaply with a Price/Earnings ratio of 6.93.
Based on the Price/Earnings ratio, IMMR is valued cheaper than 100.00% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 28.96, IMMR is valued rather cheaply.
The Price/Forward Earnings ratio is 15.44, which indicates a correct valuation of IMMR.
Compared to the rest of the industry, the Price/Forward Earnings ratio of IMMR is on the same level as its industry peers.
When comparing the Price/Forward Earnings ratio of IMMR to the average of the S&P500 Index (23.82), we can say IMMR is valued slightly cheaper.
Industry RankSector Rank
PE 6.93
Fwd PE 15.44

4.2 Price Multiples

100.00% of the companies in the same industry are more expensive than IMMR, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, IMMR is valued cheaper than 93.75% of the companies in the same industry.
Industry RankSector Rank
P/FCF 5.93
EV/EBITDA 0.02

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
IMMR has a very decent profitability rating, which may justify a higher PE ratio.
A cheap valuation may be justified as IMMR's earnings are expected to decrease with -33.01% in the coming years.
PEG (NY)0.09
PEG (5Y)N/A
EPS Next 2Y-33.01%
EPS Next 3YN/A

3

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.11%, IMMR has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 2.98, IMMR pays a better dividend. On top of this IMMR pays more dividend than 84.38% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.23, IMMR has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.11%

5.2 History

IMMR is new to the dividend game and has less than 3 years of track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

IMMR pays out 10.14% of its income as dividend. This is a sustainable payout ratio.
DP10.14%
EPS Next 2Y-33.01%
EPS Next 3YN/A

IMMERSION CORPORATION

NASDAQ:IMMR (11/21/2024, 7:32:46 PM)

After market: 8.6001 -0.06 (-0.69%)

8.66

+0.34 (+4.09%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryTechnology Hardware, Storage & Peripherals
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap278.68M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 2.11%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 6.93
Fwd PE 15.44
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)0.09
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 18.13%
ROE 22.02%
ROCE
ROIC
ROICexc
ROICexgc
OM 44.25%
PM (TTM) 62.75%
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.29
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 6.44
Quick Ratio 6.44
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)58.28%
EPS 3Y47.44%
EPS 5Y
EPS Q2Q%
EPS Next Y75.07%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)338.29%
Revenue growth 3Y3.61%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y